BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3764801)

  • 1. Heparin cofactor activity and antithrombin III antigen levels in preeclampsia.
    Friedman KD; Borok Z; Owen J
    Thromb Res; 1986 Aug; 43(4):409-16. PubMed ID: 3764801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia-eclampsia.
    Weiner CP; Brandt J
    Am J Obstet Gynecol; 1982 Feb; 142(3):275-81. PubMed ID: 7065016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma concentration of biochemical markers in pre-eclampsia-eclampsia and its association with the severity of the disease].
    Chavarría Olarte ME; González Gleason A; Lara González AL; Sojo Aranda I; García Paleta Y; Vital Reyes VS; Reyes Fuentes A
    Ginecol Obstet Mex; 2000 Sep; 68():385-93. PubMed ID: 11080945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III levels in preeclampsia.
    Aghai E; Brunstein J; Quitt M; Abramovici H; Froom P
    Isr J Med Sci; 1990 Mar; 26(3):142-3. PubMed ID: 2329037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low antithrombin III and high plasma fibronectin in pre-eclampsia.
    Graninger W; Tatra G; Pirich K; Nasr F
    Eur J Obstet Gynecol Reprod Biol; 1985 Apr; 19(4):223-9. PubMed ID: 4007230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of reduced antithrombin III activity in women with preeclampsia.
    Weiner CP
    Obstet Gynecol; 1988 Dec; 72(6):847-9. PubMed ID: 3186090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of plasma protease inhibitors in late pregnancy, during delivery and puerperium in normal women and in preeclampsia.
    Gamba G; Grignani G; Comerio D; Riccardi A; Bergamaschi P
    Ric Clin Lab; 1984; 14(3):521-5. PubMed ID: 6522962
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of high levels of heparin cofactor II in the plasma and urine of adult patients with nephrotic syndrome.
    Toulon P; Gandrille S; Remy P; Chadeuf G; Jouvin MH; Aiach M
    Nephron; 1992; 60(2):176-80. PubMed ID: 1553002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia.
    Halligan A; Bonnar J; Sheppard B; Darling M; Walshe J
    Br J Obstet Gynaecol; 1994 Jun; 101(6):488-92. PubMed ID: 8018635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterisation of an antithrombin III mutant (AT Dublin 2) with marginally decreased heparin reactivity.
    Daly M; Ball R; O'Meara A; Hallinan FM
    Thromb Res; 1989 Nov; 56(4):503-13. PubMed ID: 2609289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preeclampsia, delivery, and the hemostatic system.
    Saleh AA; Bottoms SF; Welch RA; Ali AM; Mariona FG; Mammen EF
    Am J Obstet Gynecol; 1987 Aug; 157(2):331-6. PubMed ID: 2441602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III levels in normotensive and hypertensive pregnancy.
    Weenink GH; Borm JJ; Ten Cate JW; Treffers PE
    Gynecol Obstet Invest; 1983; 16(4):230-42. PubMed ID: 6629144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory determination of heparin cofactor II.
    Ezenagu LC; Brandt JT
    Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity.
    Weenink GH; Treffers PE; Vijn P; Smorenberg-Schoorl ME; Ten Cate JW
    Am J Obstet Gynecol; 1984 Apr; 148(8):1092-7. PubMed ID: 6711644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal antithrombin III.
    Peters M; Jansen E; ten Cate JW; Kahlé LH; Ockelford P; Breederveld C
    Br J Haematol; 1984 Dec; 58(4):579-87. PubMed ID: 6518134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombin-III in preeclampsia-eclampsia. Pilot study].
    Verduzco Rodríguez L; González Puebla E; López Ariza B; Manffrini Madrid F
    Ginecol Obstet Mex; 1998 Aug; 66():343-6. PubMed ID: 9745197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
    Kobayashi T; Terao T
    Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
    Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
    Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.